LV cohort (n = 244) | N. patients (%) | N. deaths (%) | OS (%) (SE) | p-value* | Median OS, months (95% CI) | HR (95% CI) | p-value° |
---|---|---|---|---|---|---|---|
PLT DN | 157 (64.3) 87 (35.7) | 59 (60.2) 39 (39.8) | 32.4 (8.9) 16.3 (9.1) | 0.11 | 61.9 (50.0–73.8) 47.9 (43.4–52.5) | 1 (ref) 1.39 (0.93–2.10) | 0.11 |
HV cohort (n = 173) | N. patients (%) | N. deaths (%) | OS (%) (SE) | p-value* | Median OS months (95% CI) | HR (95% CI) | p-value° |
---|---|---|---|---|---|---|---|
PLT DN | 64 (37.0) 109 (63.0) | 40 (37.0) 68 (63.0) | 20.9 (6.6) 9.9 (5.4) | 0.71 | 27.5 (21.4–33.6) 27.8 (19.8–35.8) | 1 (ref) 0.93 (0.63–1.37) | 0.71 |